Koc University Digital Collections
metadata only
CC BY 4.0
C-Abl is not activated in DNA damage-induced and Tap63-mediated oocyte apoptosis in human ovary
There is a controversy in literature as to whether c-Abl is crucial for the induction of TAp63-mediated apoptosis and whether that inhibition of c-Abl with imatinib, which was designed to inhibit the oncogenic kinase BCR-ABL and c-kit, protects oocytes from chemotherapy-induced apoptosis in mice. No
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL#1047639
- A Study of Apatinib Treatment in for Advanced Ovarian Cancer#1009300
- Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer#915109
- Apoptosis: A Review of Programmed Cell Death#6788
- Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6#863474
Record · ID 955370
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive